IRS-1-Rad51 nuclear interaction sensitizes JCV T-antigen positive medulloblastoma cells to genotoxic treatment

International Journal of Cancer

Volumn 119, Issue 3, 2006, Pages 539-548

  Trojanek, Joanna ^a   Ho, Thu ^a   Croul, Sidney ^a   Wang, Jin Ying ^a   Chintapalli, Janaki ^a   Koptyra, Mateusz ^a   Giordano, Antonio ^a   Khalili, Kamel ^a   Reiss, Krzysztof ^a,b  

^a TEMPLE UNIVERSITY   (United States)

^b TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Genomic instability; IRS 1; JC virus T antigen; Medulloblastoma; Rad51

Indexed keywords

CISPLATIN; DOUBLE STRANDED DNA; INSULIN RECEPTOR SUBSTRATE 1; RAD51 PROTEIN; VIRUS LARGE T ANTIGEN;

ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CANCER THERAPY; CARCINOGENIC ACTIVITY; CELL NUCLEUS; CELL SURVIVAL; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DNA DOUBLE STRAND BREAKAGE; DNA REPAIR; DNA STRAND BREAKAGE; FIBROBLAST; GAMMA IRRADIATION; GENOTOXICITY; HOMOLOGOUS RECOMBINATION; MALIGNANT TRANSFORMATION; MEDULLOBLASTOMA; NONHUMAN; NUCLEOCYTOPLASMIC TRANSPORT; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT; VIRUS CARCINOGENESIS;

ANIMALS; ANTIGENS, NUCLEAR; ANTIGENS, POLYOMAVIRUS TRANSFORMING; ANTIGENS, VIRAL, TUMOR; ANTINEOPLASTIC AGENTS; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL NUCLEUS; CELL PROLIFERATION; CELL SURVIVAL; CISPLATIN; DNA DAMAGE; DNA REPAIR; DNA-ACTIVATED PROTEIN KINASE; DNA-BINDING PROTEINS; GAMMA RAYS; MEDULLOBLASTOMA; MICE; PHOSPHOPROTEINS; PROTEIN BINDING; RAD51 RECOMBINASE;

EID: 33745456875     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.21828     Document Type: Article

References (64)

1. Kleihues P, Louis DN, Scheithauer BW, Rorke LB, Reifenberger G, Burger PC, Cavenee WK. The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol 2002;61:215-25; discussion 26-9.
2. Longo M, Fiumara F, Pandolfo I, Lavagnini L, Blandino G. [Metastases of the sub-arachnoidal space from medulloblastoma. Computed tomography study]. J Radiol 1982;63:279-81.
3. Bigner SH, Mark J, Friedman HS, Biegel JA, Bigner DD. Structural chromosomal abnormalities in human medulloblastoma. Cancer Genet Cytogenet 1988;30:91-101.
4. Reardon DA, Michalkiewicz E, Boyett JM, Sublett JE, Entrekin RE, Ragsdale ST, Valentine MB, Behm FG, Li H, Heideman RL, Kun LE, Shapiro DN, et al. Extensive genomic abnormalities in childhood medulloblastoma by comparative genomic hybridization. Cancer Res 1997;57:4042-7.
5. Badiali M, Pession A, Basso G, Andreini L, Rigobello L, Galassi E, Giangaspero F. N-myc and c-myc oncogenes amplification in medulloblastomas. Evidence of particularly aggressive behavior of a tumor with c-myc amplification. Tumori 1991;77:118-21.
6. Zurawel RH, Chiappa SA, Allen C, Raffel C. Sporadic medulloblastomas contain oncogenic β-catenin mutations. Cancer Res 1998;58:896-9.
7. Kozmik Z, Sure U, Ruedi D, Busslinger M, Aguzzi A. Deregulated expression of PAX5 in medulloblastoma. Proc Natl Acad Sci USA 1995;92:5709-13.
8. Del Valle L, Wang JY, Lassak A, Peruzzi F, Croul S, Khalili K, Reiss K. Insulin-like growth factor I receptor signaling system in JC virus T-antigen induced primitive neuroectodermal tumors-medulloblastomas. J Neurovirol 2002;8 (Suppl. 2):138-47.
9. Patti R, Reddy CD, Geoerger B, Grotzer MA, Raghunath M, Sutton LN, Phillips PC. Autocrine secreted insulin-like growth factor-I stimulates MAP kinase- dependent mitogenic effects in human primitive neuroectodermal tumor/medulloblastoma. Int J Oncol 2000;16:577-84.
10. Reiss K. Insulin-like growth factor-I receptor - a potential therapeutic target in medulloblastomas. Expert Opin Ther Targets 2002;6:539-44.
11. Wang JY, Del Valle L, Gordon J, Rubini M, Romano G, Croul S, Peruzzi F, Khalili K, Reiss K. Activation of the IGF-IR system contributes to malignant growth of human and mouse medulloblastomas. Oncogene 2001;20:3857-68.
12. Del Valle L, Gordon J, Assimakopoulou M, Enam S, Geddes JF, Varakis IN, Katsetos CD, Croul S, Khalili K. Detection of JC virus DNA sequences and expression of the viral regulatory protein T-antigen in tumors of the central nervous system. Cancer Res 2001;61:4287-93.
13. Del Valle L, Gordon J, Enam S, Delbue S, Croul S, Abraham S, Radhakrishnan S, Assimakopoulou M, Katsetos CD, Khalili K. Expression of human neurotropic polyomavirus JCV late gene product agno-protein in human medulloblastoma. J Natl Cancer Inst 2002;94:267-73.
14. Krynska B, Otte J, Franks R, Khalili K, Croul S. Human ubiquitous JCV(CY) T-antigen gene induces brain tumors in experimental animals. Oncogene 1999;18:39-46.
15. Rollison DE, Utaipat U, Ryschkewitsch C, Hou J, Goldthwaite P, Daniel R, Helzlsouer KJ, Burger PC, Shah KV, Major EO. Investigation of human brain tumors for the presence of polyomavirus genome sequences by two independent laboratories. Int J Cancer 2005;113:769-74.
16. Del Valle L, Gordon J, Ferrante P, Khalili K. JC virus in experimental and clinical brain tumors Human Polyoviruses molecular and clinical perspectives, 1st ed. New York: Wiley-Liss, 2001. 409-30.
17. Krynska B, Del Valle L, Croul S, Gordon J, Katsetos CD, Carbone M, Giordano A, Khalili K. Detection of human neurotropic JC virus DNA sequence and expression of the viral oncogenic protein in pediatric medulloblastomas. Proc Natl Acad Sci USA 1999;96:11519-24.
18. Sullivan CS, Tremblay JD, Fewell SW, Lewis JA, Brodsky JL, Pipas JM. Species-specific elements in the large T-antigen J domain are required for cellular transformation and DNA replication by simian virus 40. Mol Cell Biol 2000;20:5749-57.
19. Khalili K, Stoner GI. Human Polyomaviruses: molecular and clinical perspectives. New York: Wiley-Liss, 2001.
20. Hunter DJ, Gurney EG. The genomic instability associated with integrated simian virus 40 DNA is dependent on the origin of replication and early control region. J Virol 1994;68:787-96.
21. Kappler R, Pietsch T, Weggen S, Wiestler OD, Scherthan H. Chromosomal imbalances and DNA amplifications in SV40 large T-antigen induced primitive neuroectodermal tumor cell lines of the rat. Carcinogenesis 1999;20:1433-8.
22. Ramel S, Sanchez CA, Schimke MK, Neshat K, Cross SM, Raskind WH, Reid BJ. Inactivation of p53 and the development of tetraploidy in the elastase-SV40 T antigen transgenic mouse pancreas. Pancreas 1995;11:213-22.
23. Ricciardiello L, Baglioni M, Giovannini C, Pariali M, Cenacchi G, Ripalti A, Landini MP, Sawa H, Nagashima K, Frisque RJ, Goel A, Boland CR, et al. Induction of chromosomal instability in colonic cells by the human polyomavirus JC virus. Cancer Res 2003;63:7256-62.
24. Woods C, LeFeuvre C, Stewart N, Bacchetti S. Induction of genomic instability in SV40 transformed human cells: sufficiency of the N-terminal 147 amino acids of large T antigen and role of pRB and p53. Oncogene 1994;9:2943-50.
25. Hoeijmakers JH. Genome maintenance mechanisms for preventing cancer. Nature 2001;411:366-74.
26. Khanna KK, Jackson SP. DNA double-strand breaks: signaling, repair and the cancer connection. Nat Genet 2001;27:247-54.
27. Castello MA, Clerico A, Deb G, Dominici C, Fidani P, Donfrancesco A. High-dose carboplatin in combination with etoposide (JET regimen) for childhood brain tumors. Am J Pediatr Hematol Oncol 1990;12:297-300.
28. Chi SN, Gardner SL, Levy AS, Knopp EA, Miller DC, Wisoff JH, Weiner HL, Finlay JL. Feasibility and response to induction chemotherapy intensified with high-dose methotrexate for young children with newly diagnosed high-risk disseminated medulloblastoma. J Clin Oncol 2004;22:4881-7.
29. Sexauer CL, Khan A, Burger PC, Krischer JP, van Eys J, Vats T, Ragab AH. Cisplatin in recurrent pediatric brain tumors. A POG Phase II study. A Pediatric Oncology Group Study. Cancer 1985;56:1497-501.
30. Walker RW, Allen JC. Cisplatin in the treatment of recurrent child-hood primary brain tumors. J Clin Oncol 1988;6:62-6.
31. Pierce AJ, Johnson RD, Thompson LH, Jasin M. XRCC3 promotes homology-directed repair of DNA damage in mammalian cells. Genes Dev 1999;13:2633-8.
32. Trojanek J, Ho T, Del Valle L, Nowicki M, Wang JY, Lassak A, Peruzzi F, Khalili K, Skorski T, Reiss K. Role of the insulin-like growth factor I/insulin receptor substrate 1 axis in Rad51 trafficking and DNA repair by homologous recombination. Mol Cell Biol 2003;23:7510-24.
33. Schindewolf C, Lobenwein K, Trinczek K, Gomolka M, Soewarto D, Fella C, Pargent W, Singh N, Jung T, Hrabe de Angelis M. Comet assay as a tool to screen for mouse models with inherited radiation sensitivity. Mamm Genome 2000;11:552-4.
34. Ludwig T, Eggenschwiler J, Fisher P, D'Ercole AJ, Davenport ML, Efstratiadis A. Mouse mutants lacking the type 2 IGF receptor (IGF2R) are rescued from perinatal lethality in Igf2 and Igf1r null backgrounds. Dev Biol 1996;177:517-35.
35. Labhart P. Nonhomologous DNA end joining in cell-free systems. Eur J Biochem 1999;265:849-61.
36. Lassak A, Del Valle L, Peruzzi F, Wang JY, Enam S, Croul S, Khalili K, Reiss K. Insulin receptor substrate 1 translocation to the nucleus by the human JC virus T-antigen. J Biol Chem 2002;277:17231-8.
37. Wang JY, Del Valle L, Peruzzi F, Trojanek J, Giordano A, Khalili K, Reiss K. Polyomaviruses and cancer-interplay between viral proteins and signal transduction pathways. J Exp Clin Cancer Res 2004;23:373-83.
38. Krynska B, Del Valle L, Gordon J, Otte J, Croul S, Khalili K. Identification of a novel p53 mutation in JCV-induced mouse medulloblastoma. Virology 2000;274:65-74.
39. Chipitsyna G, Slonina D, Siddioqui K, Peruzzi F, Skorski T, Reiss K, Sawaya BE, Khalili K, Amini S. HIV-1 Tat increases cell survival in response to cisplatin by stimulating Rad51 gene expression. Oncogene 2004;23:2664-71.
40. Del Valle L, Enam OS, Lara C, Ortiz-Hidalgo C, Katsetos CD, Khalili K. Detection of JC polyomavirus DNA sequences and cellular localization of T-antigen and agnoprotein in oligodendrogliomas. Clin Cancer Res 2002;8:3332-40.
41. Trojanek J, Croul S, Ho T, Wang JY, Darbinyan A, Nowicki M, Valle LD, Skorski T, Khalili K, Reiss K. T-antigen of the human polyomavirus JC attenuates faithful DNA repair by forcing nuclear interaction between IRS-1 and Rad51. J Cell Physiol 2006;206:35-46.
42. Paull TT, Rogakou EP, Yamazaki V, Kirchgessner CU, Gellert M, Bonner WM. A critical role for histone H2AX in recruitment of repair factors to nuclear foci after DNA damage. Curr Biol 2000;10:886-95.
43. Bergsagel DJ, Finegold MJ, Butel JS, Kupsky WJ, Garcea RL. DNA sequences similar to those of simian virus 40 in ependymomas and choroid plexus tumors of childhood. N Engl J Med 1992;326:988-93.
44. Khalili K, Del Valle L, Wang JY, Darbinian N, Lassak A, Safak M, Reiss K. T-antigen of human polyomavirus JC cooperates with IGF-IR signaling system in cerebellar tumors of the childhood-medulloblastomas. Anticancer Res 2003;23:2035-41.
45. Testa JR, Carbone M, Hirvonen A, Khalili K, Krynska B, Linnainmaa K, Pooley FD, Rizzo P, Rusch V, Xiao GH. A multi-institutional study confirms the presence and expression of simian virus 40 in human malignant mesotheliomas. Cancer Res 1998;58:4505-9.
46. Okamoto H, Mineta T, Ueda S, Nakahara Y, Shiraishi T, Tamiya T, Tabuchi K. Detection of JC virus DNA sequences in brain tumors in pediatric patients. J Neurosurg 2005;102 (Suppl. 3):294-8.
47. Del Valle L, White MK, Enam S, Oviedo SP, Bromer MQ, Thomas RM, Parkman HP, Khalili K. Detection of JC virus DNA sequences and expression of viral T antigen and agnoprotein in esophageal carcinoma. Cancer 2005;103:516-27.
48. London WT, Houff SA, McKeever PE, Wallen WC, Sever JL, Padgett BL, Walker DL. Viral-induced astrocytomas in squirrel monkeys. Prog Clin Biol Res 1983;105:227-37.
49. Major EO, Mourrain P, Cummins C. JC virus-induced owl monkey glioblastoma cells in culture: biological properties associated with the viral early gene product. Virology 1984;136:359-67.
50. Walker DL, Padgett BL, ZuRhein GM, Albert AE, Marsh RF. Human papovavirus (JC): induction of brain tumors in hamsters. Science 1973;181:674-6.
51. Zu Rhein GM, Varakis J. Perinatal induction of medulloblastomas in Syrian golden hamsterbe a human polyomavirus JC. Natl Cancer Inst Monogr 1979;51:205-08.
52. Ohsumi S, Motoi M, Ogawa K. Induction of undifferentiated tumors by JC virus in the cerebrum of rats. Acta Pathol Jpn 1986;36:815-25.
53. Small JA, Scangos GA, Cork L, Jay G, Khoury G. The early region of human papovavirus JC induces dysmyelination in transgenic mice. Cell 1986;46:13-8.
54. Bollag B, Prins C, Snyder EL, Frisque RJ. Purified JC virus T and T′ proteins differentially interact with the retinoblastoma family of tumor suppressor proteins. Virology 2000;274:165-78.
55. Staib C, Pesch J, Gerwig R, Gerber JK, Brehm U, Stangl A, Grummt F. p53 inhibits JC virus DNA replication in vivo and interacts with JC virus large T-antigen. Virology 1996;219:237-46.
56. Akyuz N, Boehden GS, Susse S, Rimek A, Preuss U, Scheidtmann KH, Wiesmuller L. DNA substrate dependence of p53-mediated regulation of double-strand break repair. Mol Cell Biol 2002;22:6306-17.
57. Bertrand P, Saintigny Y, Lopez BS. p53's double life: transactivation-independent repression of homologous recombination. Trends Genet 2004;20:235-43.
58. Restle A, Janz C, Wiesmuller L. Differences in the association of p53 phosphorylated on serine 15 and key enzymes of homologous recombination. Oncogene 2005;24:4380-7.
59. Fei ZL, D'Ambrosio C, Li S, Surmacz E, Baserga R. Association of insulin receptor substrate 1 with simian virus 40 large T antigen. Mol Cell Biol 1995;15:4232-39.
60. Zhou-Li F, Xu SQ, Dews M, Baserga R. Co-operation of simian virus 40 T antigen and insulin receptor substrate-1 in protection from apoptosis induced by interleukin-3 withdrawal. Oncogene 1997;15:961-70.
61. Prisco M, Santini F, Baffa R, Liu M, Drakas R, Wu A, Baserga R. Nuclear translocation of insulin receptor substrate-1 by the simian virus 40 T antigen and the activated type 1 insulin-like growth factor receptor. J Biol Chem 2002;277:32078-85.
62. Tu X, Batta P, Innocent N, Prisco M, Casaburi I, Belletti B, Baserga R. Nuclear translocation of insulin receptor substrate-1 by oncogenes and Igf-I. Effect on ribosomal RNA synthesis. J Biol Chem 2002;277:44357-65.
63. Drakas R, Tu X, Baserga R. Control of cell size through phosphorylation of upstream binding factor 1 by nuclear phosphatidyl inositol 3-kinase. Proc Natl Acad Sci USA 2004;101:9272-6.
64. Wu A, Tu X, Prisco M, Baserga R. Regulation of upstream binding factor 1 activity by insulin-like growth factor I receptor signaling. J Biol Chem 2005;280:2863-72.